Therapeutic Advances in Drug Safety

译名:药物安全治疗进展

SCIEJCR Q2

3-5

2026

影响因子区间

平台估算

投稿周期

26%

2025

中国作者发文占比

2800 USD

费用说明

收费

期刊简介:Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients.The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in drug safety, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest on research across all areas of drug safety, including therapeutic drug monitoring, pharmacoepidemiology, adverse drug reactions, drug interactions, pharmacokinetics, pharmacovigilance, medication/prescribing errors, risk management, ethics and regulation.

【译文】药物安全治疗进展期刊提供最高质量的同行评审文章、评论和学术评论,涉及药物在患者中安全使用的开创性努力和创新研究。该期刊具有强烈的临床和药理学重点,面向药物安全领域的临床医生和研究人员,旨在为该领域提供在线和印刷出版高质量文章的平台。编辑们欢迎关于药物安全所有领域的当前研究兴趣的文章,包括治疗药物监测、药源流行病学、不良药物反应、药物相互作用、药代动力学、药物警戒、用药/处方错误、风险管理、伦理和法规。

出版社
SAGE Publishing
语言
English
学科
医学
ISSN
2042-0986
eISSN
2042-0994
出版频率
年刊
创刊年份
2004
投稿网址
https://journals.sagepub.com/home/taw
最近更新
2026-04-02 18:16:40
Therapeutic Advances in Drug Safety

指标当前值近三年趋势
JCR分区Q2
暂无
影响因子区间3-5
暂无